Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Expert Rev Cardiovasc Ther. 2016 Jul 15;14(10):1119–1131. doi: 10.1080/14779072.2016.1210510

Figure 2.

Figure 2

A pilot and open label, randomized sequential cross-over study to evaluate if response to sotalol versus flecainide is modulated by chromosome 4q25 associated single nucleotide polymorphisms (SNPs). AFEQT, AF-specific quality of life questionnaire; AAD, antiarrhythmic drug.